Fernando Villalta

ORCID

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 6

Top Venues

Immune network

Expert opinion on drug discovery

Pathogens (Basel, Switzerland)

International journal of molecular sciences

Meharry Medical College

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Meharry Medical College May 01 1986

United States

Chair and Professor :: Microbiology and Immunology

Publications

Ayorinde Cooley, Kayla J Rayford, Ashutosh Arun, Fernando Villalta, Maria F Lima, Siddharth Pratap, Pius N Nde
Trypanosoma cruzi Dysregulates piRNAs Computationally Predicted to Target IL-6 Signaling Molecules During Early Infection of Primary Human Cardiac Fibroblasts. Immune network 22 (6) (2022)
Ayorinde Cooley, Kayla J Rayford, Ashutosh Arun, Fernando Villalta, Maria F Lima, Siddharth Pratap, Pius N Nde
Trypanosoma cruzi Dysregulates piRNAs Computationally Predicted to Target IL-6 Signaling Molecules During Early Infection of Primary Human Cardiac Fibroblasts. Immune network 22 (6) (2022)
Ayorinde Cooley, Kayla J Rayford, Ashutosh Arun, Fernando Villalta, Maria F Lima, Siddharth Pratap, Pius N Nde
Trypanosoma cruzi Dysregulates piRNAs Computationally Predicted to Target IL-6 Signaling Molecules During Early Infection of Primary Human Cardiac Fibroblasts. Immune network 22 (6) (2022)
Kayla J Rayford, Ayorinde Cooley, Jelonia T Rumph, Ashutosh Arun, Girish Rachakonda, Fernando Villalta, Maria F Lima, Siddharth Pratap, Smita Misra, Pius N Nde
piRNAs as Modulators of Disease Pathogenesis. International journal of molecular sciences 22 (5) (2021)
Xiangxu Jia, Qiujia Shao, Ahsen R Chaudhry, Ballington L Kinlock, Michael G Izban, Hong-Ying Zhang, Fernando Villalta, James E K Hildreth, Bindong Liu
Medroxyprogesterone Acetate (MPA) Enhances HIV-1 Accumulation and Release in Primary Cervical Epithelial Cells by Inhibiting Lysosomal Activity. Pathogens (Basel, Switzerland) 10 (9) (2021)
Fernando Villalta, Girish Rachakonda
Advances in preclinical approaches to Chagas disease drug discovery. Expert opinion on drug discovery 14 (11) (2019)

Fernando Villalta.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Fernando Villalta